These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 7709943)

  • 1. Interpreting trials of bone-active agents.
    Heaney RP
    Am J Med; 1995 Apr; 98(4):329-30. PubMed ID: 7709943
    [No Abstract]   [Full Text] [Related]  

  • 2. Is a change in bone mineral density a sensitive and specific surrogate of anti-fracture efficacy?
    Seeman E
    Bone; 2007 Sep; 41(3):308-17. PubMed ID: 17644058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The parathyroid hormones: bone-forming agents for treatment of osteoporosis.
    Whitfield JF; Morley P; Willick GE
    Medscape Womens Health; 2000; 5(5):E5. PubMed ID: 11113778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Letter to the editor.
    Hochberg MC; Miller PD; Wasnich RD; Ross PD; Greenspan S
    Bone; 2004 Nov; 35(5):1222-4; author reply 1225-6. PubMed ID: 15542049
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bone remodeling].
    Lerner UH; Ljunggren O
    Lakartidningen; 2006 Oct 4-10; 103(40):2972-5. PubMed ID: 17115661
    [No Abstract]   [Full Text] [Related]  

  • 6. [Parathyroid and bone. Evidence and perspective of parathyroid therapy for patients with osteoporosis].
    Wada S; Fukawa T; Kamiya S
    Clin Calcium; 2007 Dec; 17(12):1888-94. PubMed ID: 18057665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bisphosphonates and bone remodeling: effectiveness in Paget's disease, fibrous dysplasia and osteoporosis].
    Chapurlat R; Meunier PJ
    Rev Chir Orthop Reparatrice Appar Mot; 1998 Nov; 84(8):743-51. PubMed ID: 10192126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term effects of progestins on bone quality and fractures.
    Thijssen JH
    Gynecol Endocrinol; 2007 Oct; 23 Suppl 1():45-52. PubMed ID: 17943539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination and sequential therapy with PTH and bisphosphonates.
    Bauer DC
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):407. PubMed ID: 15758282
    [No Abstract]   [Full Text] [Related]  

  • 10. Is bone mineral density predictive of fracture risk reduction?
    Cefalu CA
    Curr Med Res Opin; 2004 Mar; 20(3):341-9. PubMed ID: 15025843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and efficacy of teriparatide in elderly women with established osteoporosis: bone anabolic therapy from a geriatric perspective.
    Boonen S; Marin F; Mellstrom D; Xie L; Desaiah D; Krege JH; Rosen CJ
    J Am Geriatr Soc; 2006 May; 54(5):782-9. PubMed ID: 16696744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of osteoporosis with Teriparatide rhPTH(1-34).
    San Martin J
    J Musculoskelet Neuronal Interact; 2004 Dec; 4(4):406. PubMed ID: 15758281
    [No Abstract]   [Full Text] [Related]  

  • 13. [Up-to-date treatments for osteoporosis].
    Bors K
    Orv Hetil; 2006 Feb; 147(7):301-6. PubMed ID: 17489157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D-hormones for prevention of bone loss after organ transplant.
    Sambrook PN
    J Rheumatol Suppl; 2005 Sep; 76():41-3. PubMed ID: 16142850
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium and vitamin D supplements for elderly patients.
    Feit JM
    J Fam Pract; 1997 Dec; 45(6):471-2. PubMed ID: 9420580
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacologic agents in fracture healing.
    Koester MC; Spindler KP
    Clin Sports Med; 2006 Jan; 25(1):63-73, viii. PubMed ID: 16324974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Increase in bone mineral density and its effect on fracture risk].
    Sone T
    Clin Calcium; 2005 Apr; 15(4):625-9. PubMed ID: 15802775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of postmenopausal bone loss and treatment of osteoporosis.
    Kleerekoper M
    Semin Reprod Med; 2005 May; 23(2):141-8. PubMed ID: 15852199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An update on glucocorticoid-induced osteoporosis.
    Woolf AD
    Curr Opin Rheumatol; 2007 Jul; 19(4):370-5. PubMed ID: 17551369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of beta-blockers on fracture risk.
    Reid IR
    J Musculoskelet Neuronal Interact; 2008; 8(2):105-10. PubMed ID: 18622079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.